Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)

STOCKHOLM, March 27, 2020 /PRNewswire/ — The shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company” or “Moberg Pharma”) are hereby convened to the Extraordinary General Meeting on Tuesday, 28 April 2020 at 4:30 p.m. (CET) in the Company’s premises in Bromma,…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.